Media stories about Cesca Therapeutics (NASDAQ:KOOL) have been trending somewhat positive on Wednesday, according to Accern. The research group identifies negative and positive news coverage by analyzing more than twenty million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Cesca Therapeutics earned a media sentiment score of 0.16 on Accern’s scale. Accern also assigned press coverage about the biotechnology company an impact score of 46.4481911395141 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the near future.
Separately, ValuEngine downgraded shares of Cesca Therapeutics from a “hold” rating to a “sell” rating in a report on Monday, July 24th.
Shares of Cesca Therapeutics (NASDAQ:KOOL) traded down 1.01% during trading on Wednesday, reaching $3.94. 537 shares of the company’s stock traded hands. The company has a 50 day moving average price of $3.85 and a 200-day moving average price of $3.40. Cesca Therapeutics has a one year low of $2.41 and a one year high of $6.44. The stock’s market cap is $39.19 million.
ILLEGAL ACTIVITY NOTICE: This piece was first published by Community Financial News and is the property of of Community Financial News. If you are accessing this piece on another publication, it was copied illegally and reposted in violation of United States & international copyright law. The correct version of this piece can be read at https://www.com-unik.info/2017/11/01/cesca-therapeutics-kool-getting-somewhat-positive-news-coverage-report-shows.html.
Cesca Therapeutics Company Profile
Cesca Therapeutics Inc is clinical-stage biotechnology company. The Company develops and markets integrated cellular therapies and delivery systems. The Company is engaged in developing and manufacturing of automated blood and bone marrow processing systems that enable the separation, processing and preservation of cell and tissue therapy products.
What are top analysts saying about Cesca Therapeutics Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Cesca Therapeutics Inc. and related companies.